title: Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.
authors.forename: Robert O
authors.initials: RO
authors.lastname: Friedel
authors.forename: Warren T
authors.initials: WT
authors.lastname: Jackson
authors.forename: Celia S
authors.initials: CS
authors.lastname: Huston
authors.forename: Roberta S
authors.initials: RS
authors.lastname: May
authors.forename: Nancy L
authors.initials: NL
authors.lastname: Kirby
authors.forename: Andrée
authors.initials: A
authors.lastname: Stoves
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001883:Borderline Personality Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000706:statistics & numerical data*; D010555:Personality Inventory / Q000706:statistics & numerical data*; D010865:Pilot Projects; D011594:Psychometrics; D011788:Quality of Life; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D015430:Weight Gain / Q000187:drug effects
chemical_list: D014150:Antipsychotic Agents; D018967:Risperidone